DM
Therapeutic Areas
Santhera Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Focus Area Program | Duchenne Muscular Dystrophy (DMD) | Not Specified |
| Research Portfolio | Neuromuscular Diseases | Research |
Leadership Team at Santhera Pharmaceuticals
TM
Thomas Meier, PhD
Founder, Chairman of the Board and the Scientific Committee
PG
Philipp Gutzwiller
Board Member and Chairman of the Audit & Compliance Committee
BC
Bradley C. Meyer
Board Member and Chairman of the Compensation Committee
DE
Dario Eklund
Chief Executive Officer
CI
Catherine Isted
Chief Financial Officer
SH
Shabir Hasham, MD
Chief Medical Officer
OP
Oliver P. Kronenberg, PhD
Chief Legal Officer & Corporate Secretary
MS
Marc Schrader
Chief Technology Officer
GJ
Geert Jan van Daal, MD, PhD
Chief Commercial Officer
SH
Sarah Holmes-Klotz
Global Head People & Culture